DECOMPOSITION OF BCNU (1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA) IN AQUEOUS SOLUTIONCOLVIN M; COWENS JW; BRUNDRETT RB et al.1974; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1974; VOL. 60; NO 2; PP. 515-520; BIBL. 4REF.Article

CELL CYCLE AGE RESPONSE OF 9L CELLS TO 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND MODIFICATION BY ALPHA -DIFLUOROMETHYLORNITHINE = REPONSE DES CELLULES 9L A LA 1,3BIS(2-CHLOROETHYL)-1-NITROSOUREE EN FONCTION DE L'AGE DU CYCLE CELLULAIRE ET MODIFICATION PAR L'ALPHA-DIFLUOROMETHYLORNITHINEBJERKVIG R; OREDSSON SM; MARTON LJ et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 4; PP. 1497-1500; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

THE ASSESSMENT OF RESPONSE OF MURINE TRANSPLANTABLE COLON TUMORS TO COMBINATION CHEMOTHERAPYCOWEN DM; SIEGERSTETTER J; JANIK AC et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 119-126; BIBL. 9 REF.Article

Quantitation of 1,3-bis(2-chloroethyl)-1-nitrosourea in plasma using high-performance liquid chromatographyYEAGER, R. L; OLDFIELD, E. H; CHATTERJI, D. C et al.Journal of chromatography. 1984, Vol 305, Num 2, pp 496-501, issn 0021-9673Article

CARBAMOYLATION OF AMINO ACIDS, PEPTIDES, AND PROTEINS BY NITROSOUREAS. = CARBAMOYLATION DES ACIDES AMINES, DES PEPTIDES ET DES PROTEINES PAR LES NITROSOUREESWHEELER GP; BOWDON BJ; STRUCK RF et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 11; PP. 2974-2984; BIBL. 1 P. 1/2Article

RESPONSE OF METASTATIC MALIGNANT CARCINOID TUMOR TO ADRIAMYCIN (NSC-123127)SOLOMON A; SONODA T; PATTERSON FK et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 273-276; BIBL. 9 REF.Article

REPRODUCTION AND TERATOLOGY STUDIES WITH ONCOLYTIC AGENTS IN THE RAT AND RABBIT. I. 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BNCU)THOMPSON DJ; MOLELLO JA; STREBING RJ et al.1974; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 30; NO 3; PP. 422-439; BIBL. 15 REF.Article

DISAPPEARANCE OF DISSEMINATED PANCREATIC CARCINOMA WITH COMBINED CHEMOTHERAPY = DISPARITION D'UN CANCER DISSEMINE DU PANCREAS AVEC LA CHIMIOTHERAPIE ASSOCIEELOKICH JJ; BROOKS JR.1973; ANN. SURG.; U.S.A.; DA. 1973; VOL. 177; NO 1; PP. 13-14; BIBL. 5REF.Serial Issue

BCNU (NSC-409962) IN THE TREATMENT OF BRONCHOGENIC CARCINOMAWHITTINGTON RM; FAIRLY JL; MAJIMA H et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 739-743; BIBL. 5REF.Serial Issue

EVIDENCE FOR HOST RESISTANCE IN 1,3 BIS(2-CHLOROETHYL)-1-NITROSOUREA TREATMENT INDUCED IN SYNGENEIC LSA LYMPHOMAMARUYAMA Y; WILLIAMS A; FEOLA JM et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 107-118; BIBL. 2 P.Article

PHASE II STUDY OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN THE TREATMENT OF BRONCHOGENIC CARCINOMA = PHASE II DE L'ETUDE DE LA BIS-(CHLORO-2- ETHYL)-1,3 NITROSO-1 UREE (BCNU; NSC-409962) DANS LE TRAITEMENT DU CARCINOME BRONCOGENEOLSHIN S; SIDDIQUI S; FIRAT D et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 2; PP. 259-261; BIBL. 6REF.Serial Issue

INTRACAROTID BCNU (NSC-409962): A TOXICITY STUDY IN SIX RHESUS MONKEYSCRAFTS DC; LEVIN VA; NIELSEN S et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 541-545; BIBL. 9 REF.Article

REACTION OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA WITH SYNTHETIC POLYNUCLEOTIDES.LUDLUM DB; KRAMER BS; WANG J et al.1975; BIOCHEMISTRY; U.S.A.; DA. 1975; VOL. 14; NO 25; PP. 5480-5485; BIBL. 23 REF.Article

THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210. II. PERSISTENCE OF A NITROSOUREA-INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONS = EFFET DE LA CHIMIOTHERAPIE SUR LA CROISSANCE DE LA LEUCEMIE L1210. II. PERSISTENCE D'UNE MODIFICATION INDUITE PAR LA NITROSOUREE DANS LES CARACTERISTIQUES DE CROISSANCE DES GENERATIONS DE TRANSPLANTSDEVITA VT; BRAY DA; BOSTICK F et al.1972; CELL TISSUE KINET.; G.B.; DA. 1972; VOL. 5; NO 6; PP. 459-566; BIBL. 9 REF.Serial Issue

PHASE II EVALUATION OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN PATIENTS WITH SOLID TUMORSRAMIREZ G; WILSON W; GRAGE T et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 787-790; BIBL. 13REF.Serial Issue

TREATMENT OF METASTATIC EWING'S SARCOMA WITH BCNU = TRAITEMENT DU CANCER D'EWING METASTATIQUE PAR BCNUPALMA J; GAILANI S; FREEMAN A et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 4; PP. 909-913; BIBL. 10 REF.Serial Issue

ZUR THERAPIE DES LYMPHOGRANULOMS. CCNU (1-(2-CHLORAETHYL)-3-ZYKLOHEXYL-1-NITROSOUREA) UND BCNU (1,3-BIS (2-CHLOROAETHYL)-1-NITROSOUREA) SOWIE BCNU-KOMBINATIONEN BEIM LYMPHOGRANULOM HODGKIN, STADIUM III UND IV = SUR LE TRAITEMENT DU LYMPHOGRANULOME. CCNU ((CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE) ET BCNU (BIS (CHLORO-2 ETHYL)-1,3 NITROSO-1 UREE) AINSI QUE L'ASSOCIATION BCNU DANS LE LYMPHOGRANULOME DE HODGKIN, STADE III ET IVBRUNNER KW; MAURICE P; SONNTAG RW et al.1972; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1972; VOL. 102; NO 43; PP. 1546-1551; BIBL. 11 REF.Serial Issue

Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model. CommentaryRENARD RECINOS, Violette; TYLER, Betty M; BEKELIS, Kimon et al.Neurosurgery. 2010, Vol 66, Num 3, pp 530-537, issn 0148-396X, 8 p.Article

In vivo release from a drug delivery MEMS deviceYAWEN LI; SHAWGO, Rebecca S; TYLER, Betty et al.Journal of controlled release. 2004, Vol 100, Num 2, pp 211-219, issn 0168-3659, 9 p.Article

Interferon-γ for delayed pulmonary toxicity syndrome resistant to steroidsSURATT, B. T; LYNCH, D. A; COOL, C. D et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 10, pp 939-941, issn 0268-3369, 3 p.Article

MGMT : Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agentsKAINA, Bernd; CHRISTMANN, Markus; NAUMANN, Steffen et al.DNA repair. 2007, Vol 6, Num 8, pp 1079-1099, issn 1568-7864, 21 p.Article

Interstitial docetaxel (Taxotere), carmustine and combined interstitial therapy : a novel treatment for experimental malignant gliomaSAMPATH, Prakash; RHINES, Laurence D; DIMECO, Francesco et al.Journal of neuro-oncology. 2006, Vol 80, Num 1, pp 9-17, issn 0167-594X, 9 p.Article

Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and actionGANTER, Brigitte; TUGENDREICH, Stuart; BRECKENRIDGE, Naiomi et al.Journal of biotechnology. 2005, Vol 119, Num 3, pp 219-244, issn 0168-1656, 26 p.Article

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-dimethyl-1-O-(4,6-O-2-thenylidene-β-D-glucopyranosyl)epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumorsSTEWART, D. J; GRAHOVAC, Z; VANDENBERG, T et al.Neurosurgery. 1984, Vol 15, Num 6, pp 828-833, issn 0148-396XArticle

DEGRADATION OF CARMUSTINE IN MIXED SOLVANT AND NONAQUEOUS MEDIA.LASKAR PA; AYRES JW.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 8; PP. 1076-1078; BIBL. 21 REF.Article